ArticleThe Journal of pharmacology and experimental therapeutics2016

Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell Lines.

Esther P Jane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.